Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

MRSA and E. coli detected weeks after Potomac sewage spill

22

Feb 2026

MRSA and E. coli detected weeks after Potomac sewage spill

Nearly a month after a wastewater pipe broke and spewed hundreds of millions of gallons of raw sewage into the Potomac River just north of Washington, D.C., the latest water testing results from the University of Maryland School of Public Health continue to show high levels of E. coli and S. aureus – commonly called staph, including antibiotic-resistant MRSA.

Grant funds research on prenatal massage for maternal mental health

22

Feb 2026

Grant funds research on prenatal massage for maternal mental health

The Massage Therapy Foundation (MTF) announces the award of a research grant to University of Denver, Denver, Colo. The grant will support a three-year study entitled, "Prenatal Massage: A Complementary Approach for Maternal Health and Mental Health," led by Primary Investigator Galena Rhoades, PhD.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.